CalciMedica's equity turned negative and liabilities surged 276% while net losses more than doubled, with new language explicitly raising substantial doubt about the company's ability to continue as a going concern.
The company has crossed into negative stockholders' equity territory (-$6.6M) and explicitly acknowledged substantial doubt about its going concern status, representing a critical deterioration in financial health. The new debt restrictions from the Avenue Venture loan agreement further constrain management's operational flexibility at a time when the company desperately needs capital to fund its CRAC channel therapeutics development.
CalciMedica's financial position deteriorated dramatically with stockholders' equity plunging from $14.4M to negative $6.6M while total liabilities exploded 276% to $20.2M, indicating significant new debt burden. Despite cash increasing to $11.5M, total assets declined 31% and net losses more than doubled to $29.6M, reflecting unsustainable cash burn rates. The overall picture signals a company in severe financial distress that has likely taken on substantial debt financing to maintain operations while burning through capital at an accelerating pace.
Liabilities grew 275.8% — significant increase in debt or obligations, assess impact on financial flexibility.
Capital expenditure jumped 250% — major investment cycle underway; assess returns on deployment.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Net income declined 115.8% — review whether driven by operations, interest costs, or non-recurring items.
Cash position surged 45.2% — strong cash generation or capital raise providing significant financial cushion.
Total assets contracted 31.3% — asset sales, write-downs, or balance sheet optimization underway.
Current assets declined 31.2% — monitor working capital adequacy and short-term liquidity.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →